Astellas’ fezolinetant fails to meet pre-defined endpoints for efficacy in Moonlight clinical trial Read more
Bayer submits application in EU for extension of finerenone to include early stages of CKD associated with type-II diabetes Read more
Sanofi and Seagen announce collaboration to develop and commercialise multiple novel antibody-drug conjugates Read more